Track 1: Discovery & Preclinical

Designed for discovery scientists, pharmacologists, translational researchers, medicinal chemists, biomarker specialists and preclinical R&D leaders focused on identifying, validating and advancing novel non-opioid pain mechanisms from target discovery through IND-enabling studies.